Register Now: Image-Based Risk: The Next Frontier in Breast Cancer Screening
|Articles|March 15, 1995

Elscint reorganizes high-tech sales staffs

Elscint has reinforced its reputation for ongoing structural change by again reorganizingits nuclear medicine and CT/MRI sales and marketing groups. Changes announced March 1 are intended to give the units clearlydefined lines of responsibility,

Elscint has reinforced its reputation for ongoing structural change by again reorganizingits nuclear medicine and CT/MRI sales and marketing groups.

Changes announced March 1 are intended to give the units clearlydefined lines of responsibility, according to Donald J. Southard,vice president of sales and marketing. The key appointment isthe selection of John Ariatti as business unit director and actingwestern regional manager for CT/MRI.

Ariatti was formerly director of sales, marketing and customersupport for Otsuka Electronics in Fort Collins, CO. Prior to that,he was MRI marketing director and CT business unit manager forToshiba America Medical Systems.

Elscint Ltd., the parent company of Elscint, Inc., purchasedOtsuka's MRI business. Those assets have been renamed ElscintMR, Inc.

Israel Ohana has departed as nuclear medicine product managerand Southard has temporarily assumed that role. Southard joinedElscint as part of a 1994 restructuring effort, after servingas president and CEO of Serviscope, an independent service organizationin Wallingford, CT.


Related to this article

Emerging Research Insights and New Advances in Neuroradiology
Catch up on key neuroradiology news and research from the past month, including recently published studies involving white matter hyperintensity findings on brain MRI, MRI-enhanced amyloid PET and the newly FDA-approved PET agent floretyrosine F18 for glioma imaging.